Differences on metabolic behavior between intra and extrahepatic cholangiocarcinomas at 18F-FDG–PET/CT: prognostic implication of metabolic parameters and tumor markers

被引：0
作者：
A. Sabaté-Llobera
L. Gràcia-Sánchez
G. Reynés-Llompart
E. Ramos
L. Lladó
J. Robles
T. Serrano
J. Mestres-Martí
C. Gámez-Cenzano
机构：
[1] Hospital Universitari de Bellvitge-IDIBELL,Department of Nuclear Medicine, PET Unit
[2] Institut Català d’Oncologia-Hospital Duran i Reynals,IDI
[3] Hospital Universitari de Bellvitge-IDIBELL,Department of Medical Physics
[4] Hospital Universitari de Bellvitge-IDIBELL,Department of Surgery
来源：
Clinical and Translational Oncology | 2019年 / 21卷
关键词：
FDG–PET/CT; Cholangiocarcinoma; SUVmax; Tumor markers; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：324 / 333
页数：9
相关论文
共 50 条
[31]   The prognostic role of 18F-FDG PET/CT baseline quantitative metabolic parameters in peripheral T-cell lymphoma [J].
Xia, Jun ;
Zhu, Hua-Yuan ;
Liang, Jin-Hua ;
Ding, Chong-Yang ;
Wang, Li ;
Wu, Wei ;
Cao, Lei ;
Li, Tian-Lv ;
Li, Jian-Yong ;
Xu, Wei .
JOURNAL OF CANCER, 2019, 10 (23) :5805-5811
[32]   Metabolic Characteristics of Castleman Disease on 18F-FDG PET in Relation to Clinical Implication [J].
Lee, Eun Seong ;
Paeng, Jin Chul ;
Park, Chang Min ;
Chang, Won ;
Lee, Won Woo ;
Kang, Keon Wook ;
Chung, June-Key ;
Lee, Dong Soo .
CLINICAL NUCLEAR MEDICINE, 2013, 38 (05) :339-342
[33]   Prognostic value of preoperative metabolic tumor volume measured by 18F-FDG PET/CT and MRI in patients with endometrial cancer [J].
Chung, Hyun Hoon ;
Lee, Inki ;
Kim, Hee Seung ;
Kim, Jae Weon ;
Park, Noh-Hyun ;
Song, Yong Sang ;
Cheon, Gi Jeong .
GYNECOLOGIC ONCOLOGY, 2013, 130 (03) :446-451
[34]   Prognostic value of metabolic tumor volume and total lesion glycolysis assessed by 18F-FDG PET/CT in endometrial cancer [J].
Erdogan, Mehmet ;
Erdemoglu, Evrim ;
Evrimler, Sehnaz ;
Hanedan, Candost ;
Sengul, Sevim S. .
NUCLEAR MEDICINE COMMUNICATIONS, 2019, 40 (11) :1099-1104
[35]   Inverse Prognostic Relationships of 18F-FDG PET/CT Metabolic Parameters in Patients with Distal Bile Duct Cancer Undergoing Curative Surgery [J].
Yi H.K. ;
Park Y.-J. ;
Bae J.H. ;
Lee J.K. ;
Lee K.H. ;
Choi S.H. ;
Lee K.-H. ;
Kim B.-T. ;
Choi J.Y. .
Nuclear Medicine and Molecular Imaging, 2018, 52 (5) :334-341
[36]   Prognostic Significance of 18F-FDG PET/CT Metabolic Parameters and Tumor Galectin-1 Expression in Patients With Surgically Resected Lung Adenocarcinoma [J].
Zheng, Hongna ;
Cui, Yan ;
Li, Xuena ;
Du, Bulin ;
Li, Yaming .
CLINICAL LUNG CANCER, 2019, 20 (06) :420-428
[37]   18F-FDG PET/CT metabolic parameters and HER2 expression in colorectal cancer [J].
Yang, Ziyi ;
Liu, Shuai ;
Sun, Yuyun ;
Xu, Junyan ;
Jiang, Jinjin ;
Ma, Xiaoxi ;
Zhang, Yingjian ;
Song, Shaoli .
NEOPLASMA, 2021, 68 (04) :875-881
[38]   The correlation of 18F-FDG PET/CT metabolic parameters, clinicopathological factors, and prognosis in breast cancer [J].
Y.-H. Qu ;
N. Long ;
C. Ran ;
J. Sun .
Clinical and Translational Oncology, 2021, 23 :620-627
[39]   Whole-tumoral metabolic heterogeneity in 18F-FDG PET/CT is a novel prognostic marker for neuroblastoma [J].
Liu, Jun ;
Ren, Qinghua ;
Xiao, Haonan ;
Li, Siqi ;
Zheng, Lingling ;
Yang, Xu ;
Feng, Lijuan ;
Zhou, Ziang ;
Wang, Huanmin ;
Yang, Jigang ;
Wang, Wei .
CANCER IMAGING, 2024, 24 (01)
[40]   Prognostic Value of Metabolic Activity Measured by 18F-FDG PET/CT in Patients with Advanced Endometrial Cancer [J].
Kim H.J. ;
Choi J. ;
Jeong Y.H. ;
Jo K.H. ;
Lee J.-H. ;
Cho A. ;
Yun M. ;
Lee J.D. ;
Kim Y.T. ;
Kang W.J. .
Nuclear Medicine and Molecular Imaging, 2013, 47 (4) :257-262
12345